<SEC-DOCUMENT>0000030554-13-000049.txt : 20131106
<SEC-HEADER>0000030554-13-000049.hdr.sgml : 20131106
<ACCEPTANCE-DATETIME>20131106104252
ACCESSION NUMBER:		0000030554-13-000049
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20131106
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20131106
DATE AS OF CHANGE:		20131106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DUPONT E I DE NEMOURS & CO
		CENTRAL INDEX KEY:			0000030554
		STANDARD INDUSTRIAL CLASSIFICATION:	PLASTIC MATERIAL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS) [2820]
		IRS NUMBER:				510014090
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-00815
		FILM NUMBER:		131195123

	BUSINESS ADDRESS:	
		STREET 1:		1007 MARKET ST
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19898
		BUSINESS PHONE:		3027741000

	MAIL ADDRESS:	
		STREET 1:		1007 MARKET ST
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19898
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>dd116138-k.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using WebFilings 1 -->
		<!-- Copyright 2008-2013 WebFilings LLC. All Rights Reserved -->
		<title>DD 11.6.13 8-K</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s3BF4250D7A175FF659C32903D120B1F2"></a><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">WASHINGTON, D.C. 20549</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM&#160;8-K</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date of Report (Date of Earliest Event Reported) </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">November 6, 2013</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">E. I. du Pont de Nemours and Company</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact Name of Registrant as Specified in Its Charter)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="30%"></td><td width="4%"></td><td width="31%"></td><td width="4%"></td><td width="31%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1-815</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">51-0014090</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or Other Jurisdiction</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(I.R.S. Employer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Of Incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">File Number)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identification No.)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1007 Market Street</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Wilmington, Delaware 19898</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of principal executive offices)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registrant&#8217;s telephone number, including area code:&#160;&#160; </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(302) 774-1000</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160; Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160; Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160; Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160; Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><br><div></div><hr style="page-break-after:always"><a name="s087DEA695F9CD51627382903D15EA4EC"></a><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 7.01</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Regulation FD Disclosure</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 6, 2013, DuPont issued a letter to shareholders. A copy of the letter is furnished herewith as Exhibit 99.1.&#160;&#160;The information contained in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed by the Registrant under the Securities Act of 1933, as amended, or the Exchange Act.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Non-GAAP Measures: </font><font style="font-family:inherit;font-size:10pt;">The letter to shareholders contains certain non-GAAP measurements that management believes are meaningful to investors because they provide insight with respect to ongoing operating results of the company.  Such measurements are not recognized in accordance with GAAP and should not be viewed as an alternative to GAAP measures of performance. Reconciliations of non-GAAP measures to GAAP are available on the company&#8217;s Investor Center at </font><font style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;">www.dupont.com</font><font style="font-family:inherit;font-size:10pt;">&#32;under &#8220;Key Financials and Filings.&#8221; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Forward-Looking Statements</font><font style="font-family:inherit;font-size:10pt;">:  The letter to shareholders contains forward-looking statements which may be identified by their use of words like &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;will,&#8221; "believes," &#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;anticipates&#8221; or other words of similar meaning.  All statements that address expectations or projections about the future, including statements about the company&#8217;s growth strategy, product development, regulatory approval, market position, anticipated benefits of acquisitions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward-looking statements.  Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized.  Forward-looking statements also involve risks and uncertainties, many of which are beyond the company&#8217;s control.  Some of the important factors that could cause the company&#8217;s actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, weather events and natural disasters; ability to protect and enforce the company's intellectual property rights; and successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses.  The company undertakes no duty to update any forward-looking statements as a result of future developments or new information.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Statements and Exhibits.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d)&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Exhibits</font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1&#160;&#160;&#160;&#160;Letter to Shareholders dated November 6, 2013.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:54px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:60px;text-indent:-60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;">&#32;2</font></div></div><hr style="page-break-after:always"><a name="s1DC49FAFE00775B4532E2903D17D2D89"></a><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="50%"></td><td width="50%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">E. I. DU PONT DE NEMOURS AND COMPANY</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Registrant)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Barry J. Niziolek</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Barry J. Niziolek</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice President and Controller</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 6, 2013</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;">&#32;3</font></div></div><hr style="page-break-after:always"><a name="s624EAC4A327C187184A62903D1AC8EA6"></a><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT INDEX</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:682px;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="60px"></td><td width="4px"></td><td width="28px"></td><td width="589px"></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-align:center;">Exhibit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-align:center;">Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Letter to Shareholders dated November 6, 2013.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;">&#32;4</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dd-ex991_2013116x8k.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using WebFilings 1 -->
		<!-- Copyright 2008-2013 WebFilings LLC. All Rights Reserved -->
		<title>DD-Ex.99.1_2013.11.6_8K</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="sF46F8879B3FFCF6A5CA42903D08430A9"></a><div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Exhibit 99.1</font></div></div><br><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:288px;font-size:10pt;"><img src="exhibit991image111613.gif" style="height:58px;width:160px;"><font style="font-family:inherit;font-size:10pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Ellen Kullman</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chair of the Board and</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Executive Officer</font></div><div style="line-height:120%;padding-bottom:13px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:13px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 6, 2013</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dear DuPont Shareholders:</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DuPont&#8217;s recently announced separation of our Performance Chemicals segment definitively positions DuPont as a higher growth, higher value, less cyclical company.  This separation will result in two strong companies with distinct growth and cash generation strategies and tailored capital structures and, as a result, drive substantial value. We will be sharing more details about Performance Chemicals and its prospects at a later time.  Now, I would like to briefly introduce you to the next era of DuPont and outline how it will generate even greater value for shareholders. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#cc0000;">DELIVERING HIGHER GROWTH, HIGHER VALUE</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Over the past few years, we have deliberately upgraded our portfolio - acquiring Danisco, divesting Performance Coatings, and making the decision to separate Performance Chemicals - to position DuPont as a higher growth, higher value company, well equipped to drive revenue and profit growth through science-based innovation and our significant competitive advantages.  </font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Now, our resources are fully focused on three priorities: </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Agriculture &amp; Nutrition - </font><font style="font-family:inherit;font-size:10pt;">extend our leadership across the high-value, science-driven segments of the Agriculture and Food value chain;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Advanced Materials </font><font style="font-family:inherit;font-size:10pt;">- strengthen our lead as a provider of differentiated, high-value advanced industrial materials;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Industrial Biosciences</font><font style="font-family:inherit;font-size:10pt;">&#32;- build transformational new bio-based businesses by combining our world leading science with expertise and resources from our Advanced Materials and Agriculture &amp; Nutrition businesses. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#cc0000;">DUPONT IS UNIQUELY POSITIONED TO CAPITALIZE ON SIGNIFICANT GROWTH OPPORTUNITIES</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DuPont&#8217;s businesses serve markets where the increasing demand for more and healthier food, renewably sourced materials and fuels, and advanced industrial materials is creating substantial growth opportunities. Our unique combination of sciences, proven R&amp;D engine, broad global reach, and deep market penetration are distinctive competitive advantages that position us to continue capitalizing on this enormous potential. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">No competitor has our combination of biology, chemistry, materials science, and engineering.</font><font style="font-family:inherit;font-size:10pt;">&#32;All of our businesses benefit from our unique and broad portfolio of core technologies driving new product innovation and generating sales and margin growth. </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With 3,845 new patents issued in 2012 alone, we now have over 25,000 active patents worldwide, illustrating our strong track record of product innovation. This product innovation includes 2012 sales of $800 million of DuPont</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#8482;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;Solamet</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;photovoltaic pastes for solar cells and $350 million of renewably sourced materials, and we are on track to exceed $900 million of DuPont</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#8482;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;Rynaxypyr</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;insect control product sales in 2013.</font></div></td></tr></table><br><div></div><hr style="page-break-after:always"><a name="sF46F8879B3FFCF6A5CA42903D08430A9"></a><div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Exhibit 99.1</font></div></div><br><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DuPont&#8217;s global reach, market penetration, and trusted brand benefit all our businesses. </font><font style="font-family:inherit;font-size:10pt;">Our presence in over 90 countries, with emphasis on rapidly growing emerging markets, gives us the ability to find new opportunities for existing products and create new customer solutions that can be leveraged across our businesses worldwide. </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are opening up new markets for products from the Danisco acquisition and increasing margins by leveraging our global sales and marketing infrastructure. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Agriculture business accelerates local market penetration for other DuPont businesses by capturing strategic first mover advantage in emerging economies. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our global science infrastructure - including laboratories, competency centers and customer-focused innovation centers - enables us to connect scientists across businesses and disciplines and deliver market-driven solutions. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#cc0000;">OUR STRATEGY IS WORKING: DELIVERING SUPERIOR RESULTS AND INCREASED SHAREHOLDER VALUE</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The work we have done over the past several years to improve our operations and enhance our portfolio has delivered superior results:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Generated total shareholder return of 193% since year end 2008, </font><font style="font-family:inherit;font-size:10pt;">compared to 116% for the S&amp;P 500 and 101% for our proxy peers during the same period.</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consistently returned capital to shareholders</font><font style="font-family:inherit;font-size:10pt;">,</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">outperforming proxy peers</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">by approximately 10% and the S&amp;P 500 by approximately 18%.</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">2</sup>&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Delivered cost reductions</font><font style="font-family:inherit;font-size:10pt;">&#32;of more than $2.2 billion and cumulative working capital savings of $2.6 billion.</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">3</sup>&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Increased segment operating margins</font><font style="font-family:inherit;font-size:10pt;">&#32;from 10.9% in 2008 to 17.6% in 2012 and net income by more than two times, in both cases excluding the impact of the loss of our legacy Pharmaceutical royalty income.</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">4</sup>&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Improved Agriculture&#8217;s competitive position</font><font style="font-family:inherit;font-size:10pt;">, gaining six points of market share in corn and over 10 points of market share in soy in North America since 2008.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#cc0000;">GOING FORWARD: ACCELERATING GROWTH, DRIVING VALUE FOR SHAREHOLDERS</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DuPont has reinvented itself many times in its 211 year history, and we are doing it again. By creating two strong, independent companies, the next era of DuPont will see our resources, talent, and science deployed to capitalize on the significant growth opportunities created by global population growth, economic development, and sustainability.  Through innovation, execution, global reach, and continuous portfolio assessment, we will continue our track record of delivering value: accelerating the achievement of our long-term growth targets while delivering near-term value to investors.  </font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I look forward to sharing our progress over the coming months as we work toward establishing two strong, independent companies and continue to build the value of DuPont.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thank you for your investment. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;"><img src="ellenssignaturefor116138k.jpg" style="height:53px;width:258px;"></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ellen Kullman</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chair of the Board &amp; Chief Executive Officer</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">More information, including forward-looking statements and reconciliations of non-GAAP measures, is available on the Investor Center at </font><font style="font-family:inherit;font-size:10pt;color:#0000ff;font-weight:bold;text-decoration:underline;">www.dupont.com</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;under &#8220;Key Financials and Filings.&#8221;</font></div><br><div></div><hr style="page-break-after:always"><a name="sF46F8879B3FFCF6A5CA42903D08430A9"></a><div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Exhibit 99.1</font></div></div><br><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">_______________________</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1.</sup>&#160;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">USD market-cap weighted. Assumes dividends are re-invested from 31-Dec-2008 to 31-Oct-2013. Proxy Peers consists of 3M, Air Products, Baxter Intl, Boeing, Caterpillar, Dow, Emerson, Honeywell, Ingersoll Rand, Johnson Controls, Johnson and Johnson, Kimberly Clark, Merck, Monsanto, Proctor and Gamble, Syngenta AG, and United Technologies.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">2.</sup>&#160;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Based on 2009-2012 annual total dividends and share repurchases as a % of average annual market cap. Calculations for Proxy Peers and S&amp;P 500 represent an average of the annual median of the components as of each year end.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">3.</sup>&#160;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Timeframe: from 2009 to 2012.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">4.</sup>&#160;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income is defined as income from continuing operations after income taxes (GAAP), excluding significant items and non-operating pension &amp; other post-employment benefit (OPEB) costs.</font></div></td></tr></table><br><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ellenssignaturefor116138k.jpg
<TEXT>
begin 644 ellenssignaturefor116138k.jpg
M_]C_X``02D9)1@`!`0$!6P%;``#__@`]35),3%]'4D%02$E#4SI;14E?1%50
M3TY47T1%7TY%34]54E-=14Q,14Y?2E]+54Q,34%.7U-)1RY%4%/_VP!#``$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0'_VP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1
M"``M`-@#`2(``A$!`Q$!_\0`'@`!``("`P$!`0````````````D*!P@!!08"
M!`O_Q``S$``!!`,``@$"!00`!04````%`P0&!P$""``)$10A"A(3%3$6%T%1
M(B-A<?"!D:&QT?_$`!0!`0````````````````````#_Q``6$0$!`0``````
M````````````T?#_V@`,`P$``A$#$0`_`+_'CS%-XW1!N>*HFMT66K)$8-7X
MK4S(U8A"9C8TC38[O6@_387"H`$D<O.J_5/6^%40P5ZHU;Y6?N\(#VCMTA5"
M]BGXHDK7[4727#_+5KQ[HJ;L]3(2<=[U^CS'4H>OU2CR.*3X`'LN>P8]+OS'
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MHU;T^O#V!TI[+.=FW25$"9\`B7]:RRNRP"R0@H-)0TNA:S),VQV6CIV4Q0^/
M_3(L'+$_$Y,=".]'&S;#U,DS(,6F]'D"'KY]N]`]<]D3/AWU\\UJE..^9*R+
M:RSJ.%M0M?T3&Y@P,,14-KVIX*%CN@LQ%9,E@WF/FM"4:<ETP18V`C!*(L=9
M&_D[[*[BYFX'J?\`O)T_9#.!19Z9:Q:+#6XXI))I/YF1255%0JOH5'VI"1RZ
M3DM45-TF`MBHBR:Z+$B[L:*;N7R(;:>/(]_6I[$J[]FW/IGH:LJON"IHZ%M:
M;U,O'+J!!0,G<F8+@3DJ29H@#D@'+B]%RV!#C;5_AR/D(HX&=HZK#=E5I",9
MQG'SC.,X_P!X^^/`>/'GC["ES:OX),YT]9.B3.&121RQV.8[(Z/2#:-!7QQ=
MBTW<[IM]7+Q)ANV1V7431PHKKE7?1/\`-M@(]NO?:=3?+EIB^<H;570/7_5)
M<`A*]^<>2J[ULV=PV(OE,("YG;)9V6!0VIXF3<[)HL'\Q/M"+Y)=!^Q#NAJJ
M;S;J>#/9PGV)<?0G-5D\Q7-R+TAS>(KJ63:J;=(PB2;OH3:C9^YA\C!2>`&"
MPAW^JFQTR4'KZM]V7[B/RT=$OE]JPQQZ98+7\)]?L([`DZ0MO;/:486[4Z?M
M^0/</I#*3MI)D)^GB2R=]MNX0B=90A\QB\7C2*K:-Q(2'=:C![==X1<.M)_P
MYD-E]UJ>P/VJV.H^(%_85U1*5JC(EVY!%WCF^D3TGBE<Z#4WZFV[,'H](DXV
M/9ZZ:XT90ACC'RCJWQJ%C.P;/KRJ!(D[94TC4&#GIA#:_"$9.7:"&I:;V%(Q
M\1@\4&J.U$\/3\JDI4>%!C&^%'1`@Z2013SG.V=?=_\`G_M_/D)?LU,.KN[#
M]5O$,+53=R1QU@`[QM]#+=5=J!Y]XN:$9$V>FM\)[IH)RR\)#7,=CJ>NJBST
MTQ43WU29(NEL96Z]]ME&<]39+F^DH[)>T^Y3Z*R<3Y!YQ6'R:<,G&C;+A4W;
M\JU6WB%'086EL@]/2*=$FI-F*7T(#P!!OC=9$)7<9QG.<8^?M]L_;.,?^F<X
M^,_]?C.?C/VS]_MYSY'5Z[><>CJ<B%I6MV);B]D=1]0SY&V;8B\7/&GE$4GL
MS!M8Q$*;H,`94W5%Q"%1-@,'&Y`M^<G.9.D_D!!RX1_;]_)%?`XSG&,9SG^,
M8^<^1/5)[K?7Y>75FW(M8VJ8D\U<RZ35O'+&:PD_I0$XM.(",GS]702[5$L0
MJ63EJ%1>$F8P4[5:&F[%Q@&1)*[LTW?5>WZRK9=U33'%?.LK7@U_>PZYF?-4
M>GC'"F"M7U$VBQVQ>E[6$JI_.Z!>(TK%Y$P`N4<9=-9%)1#EKLW<()O&VIG+
M'/-,33N:K*,Y;BPB'\'>D4/+("W',T$7;*R?87;L$1"F5B#Q9LZWE4BY[I>3
MF"<^G!-ZB;6MZY5==$W;L0^=,0L-$RHP,P<E"Q!D,&LT<N'9`@[;L6+5#7XQ
MLNY=NE$6S='7.V,;*K*IIXSG7&=OG;&,_OQG&<8SC.,XSC&<9Q_&<9^^,X_Z
M9QY0X]C-@]%>\&]JIYZ@=U':IXGN+M,_RYSM4U>K9_=NF(3S(NN=[-[CM!^F
MB@F:HRLV8MQ"*;C&'KT.2L5V$(.F0TR*?OW]ZR.`AL4CP.-"$ED!,?$#`8M!
M9=P\71&B&+<<P26<N%%W+E5)FV1T6<+JJ*K*:[*J[[;[[;9#O/'GS^;&/GYS
M\?EQ\YSG&<:XQ_G_`(LX_+]O\_?YQ_GX\^L9QG'SC/SC/WQG'\9Q_OP'CSC&
M<9_C.,_X^V?G[_Z\YSG&/YS\?]_`>/./G'S\?/W_`,8_W_OX_P!_'SCY^/X^
M?OYSX#QX\>!BF\;MJOG"I)_>=VS0-7E55C''LIFLP/.-FX\.(98UU_-^5+7=
MT]?OG2K88'$#T7)0V8>,1`IH[(O6S=2NI/.([2]^\TB%M]HU8[Y?]=4+482'
MGRC2<4A+7LWHQB\<.GK2PKALYR,*3KF*N#C-,<[:4C!BS242-D03?RTH/("P
MI/.W_N:YZZMNA[Q5-*,H<7V'3//]Z'+;Z&XO?6W&J;4O]^(C39*B7;B0S460
MAIV/558&7DV-0N2;;,3[A(5G4<^4:_JL/$H=?>^.\%W8JG/590')S3=5H@QL
M'M/KEA-VB>RZ.^A!VM6G/`-U(G6C1UM^NAIH<2^H02UTV3UV=:_3A)=S5P;Q
M)Q!%&P;F[G6GJ5%1]HZ56D`2-#<RO=MLGIN]>R.R)#DG-B^VR3;39T0/R9WG
M]-'7*BNJ>F,:P<]R=Q*^X673+U&>KBSGQ%I(,J#^\>WHDR>/JEY\I)L_PU.0
M"&&M=AC>U9Y<#MH^A2#:)GF8)V%1D`]D>)#U944B>WB7J/NOJ9RU->U;N2R^
MI(PZ=,C)/CRC1N_-'%&KMMKHLVCLFBT8(N[7N@`"()I/QB]A3QE@B\02=%PJ
MFGRRQB1#UW>QOB[I;K&5^J-KZR:YYYZM>U#*MXG?4(N:.R*EY)6-6B:N4C\#
MBU%"1<(*PERDP>2L.R*+(*-#ILOJZ0SERZ<D0E5X@XAYE]:/-(&@J`CP^%U_
M#F2I^82PZ[:8D4VD^!S=.2V;9<E6U;I/#I1)AHL_>*?1A`(MLU"@V8B/"V+!
MO5Y9SGHSW8^S2Z9SSHVET1HKER72[E:@NQ51@4C57,\/:K(L^@.C>>B!9;]J
MN/KOI)5@[KFKG@H0X$\X57D-9[\RXDY"(*M)>V_I[O/I-^.*^T3V)7AUI$<D
MV1\ORA48('R]R"450RDYTA\VAL&4=S^W(:+>ZYV9MYE,6"A=-)')UHXQE5#?
MQ\-]+_6%#I'ZBY!]M]S<M\7/9S8,NAW-,'YDH,_(ZL%V3+"\T.PZO+TDV'4G
M%@V1TZ1S'%G@%X0!#OIFB"RJR6SI8,>>R/KN.^G_`)5YY]:7K`K#^J.RKK:;
M5%RA3<=U5F!N`CBCIPK++^GNA#5_L5*9D1IT93+399LSE4S*'9K(UG47BTKU
MUV:U[NJ+TW\'4*`]J?9VMD]+BJ]37F:ZJJ4XN.TIZ1W(R(J%AL2`-6YXY'8V
MY=;0@%/I2W!`7;(2,?R:1C7!'5/34!K^&7A$"Z96Z8H'V+]U4Y.9K7+F!WE8
M.9;%+$Z*MA\4+,B,AEZ/04Q#K&(&9DK<.!8&M8_%%\X0$(H"G`T8Z>BUNZL[
M\*9ZR;8E-52B7$^DC92)&9/(KBD,DN5[+[$ZG.GUAB[8E=]H2D44F*>XW]O6
M;8;UL[@C5TU(O-\I-BNVI?`9]AWXD#UBV%(:;A4&F5SS2?6XWASA_!810EA3
MT_3^)P@T<"&UP.(.QD,>!$F>CS30\*BQV:$@*B+O!-JWU:.,ISM/F3,HR=CG
M[9%XQ?-G+)XT<IZJMW35RDHV<METM\;:J(.$%%$5=-L9QNEOMC^,^85Y[YBY
M\Y0KL?4_-U/5_2E>C<_JHQBNXV/CC)T[SC_FDRZ[-+4@>,NLYSN]-G7I(N_4
MSLJ\>KJ;9VSG7.?C'S_\?;[Y_P`8Q\YQCYSG[8^<X^_@46_:%T!>_J:Y7M'T
M\OM-A-#=>2,A7G`W84C/;:0JA^2['EC)*^J/N1)LV+S;<ES1'#[H!%Y6P1,.
M3U5S\,^;Z,2$(U&OKC/+=/UQS#RW1E)UV0'?VSIBFX-"XZ?^&[%F3`16*,&^
MTL?*?JY;IJ'M4',G*.MULZ[N"#IRJIMG;??,'G,(8)['_=[U-V48:KR:A_6`
M"SPWS(H^;#E8P\Z4-)E"'4D]%IZ*$-'QF*-B>((U)_K)(.`Y<(\PT2>,6RFD
MJ_LEYEO/L#ETYSA15T)4'O9\Q@,=MV=-=RS23[\\JR!':Z8G`R09H[6$S"8P
MW5S'1KIRDF-<,GI$40=CVI'=^W"L%RA7U(^_[VG]R]'7E<=XQVG:BKJOZ>Y5
MHJNI?/>>E;OY"<S*79Q<,@DX)['YO,JKF5H1D\7W%!5AS?4^?#(G"Z*D="C<
MVG*EY^X5]9-$2IY5T!IKEBD(2'<R2PIA\,`+7]O'Y476D-DV-(G3N32I\ELO
ME)(K,9$9*+*JH,66^ZJC9KG6_HOT\<ZVXSY[.4G-;@XEN7E&MF%-4)>'*4I9
M0R;1FFA;7=NSIR4,SHJ0`;`J_9??8J[C<D8J.5BZCUZD80R6,ID<'0[T>!9[
M*X_*O8?VQU5[)AL-/)2.)TO?!B.1+F1H;9:*)AI!(J'@+%K'YO(1"2F4TG$H
M)O`+C91QNZCBVCA1+P,3^N[V76_[1?8!TC;U(6!O`/5MR178ZKF`24P<8#DW
M1EW39I_5JEJEW<L#H2^O(=!HR.>.!0Q0B$77#O8T1D`S#B0&6(+]5;>UV?\`
ML0]DL<HSUR3>)N^'^1F;J>=W=1EHL@=A]GD"6A8-%*#J`H;8MDFZ;M\T6D&]
MFB23!`BU#&RX9V0B\?00G.8KG]"O,-Y='6]=<IO+K\'5G0<KC4]OKCJ`7@X@
M?+EQS*-1D)$4R4]B4;",946'%@D?'IF0NDN;H+KX7U8N1S!;Z#3SLI_#@^M"
M46K.)QI&[JAU666YB9"P.0ZNNN4U3R-+2\-"I`1)<M4U?)QY\HY^B02V59(2
MM`0DYRY78#V7UY#1R$6WN5]FD"*=]<3Q_B;HZE][2J$%TA0EI=(R?<M(N;.+
M)7V,+J>)0JUYG9T>&F*]<66$C4`LD=%H:N;V3:G'VC.6*LV.2HMQN7W0>YV]
M/'HKG-441:3-=K)086G'%Q:2:.2:V)O*.F9D/BM[=):?0&6[RPK99165S>TA
MK0>0W_*\#`Q:;X=%Q&KMC-M">%.-:YH$SRQ"^8*-`\ZR1!9"4TVVK:,+0"6J
M./I<KD)>!>L'+>6&E]V+%=8](MB9M1TQ9N]B'U+5!5/3^O?0YZ@*OFY"PHEP
M%06)*3:E&3G23A3<_C"#<RTW8O\`43!)\>D\&`[J-%54$5@L=8N&::JWT*K7
M993.P:`^KC3D6BHR5[\Z#L:AN<&R_/\`6E!<F518MZ5*[.<K>OJJH\.(UZ!E
MA1E(-4$[DOXZN^O"\T6OU1).3'`T.6U6)A"&7L,WN<]V-B=>WCQ-2W&U0="3
MWB^0W\#E8.:1,#,JF?\`L`MBIY%&R0*K*AD,@CPJ2,*JBLN(!1LIE3)KLX)E
M363[<>BG"PRSZUQ$?2)ZDX/*$)C'O7QRXD=;$?W5JJ5K$7)!S1]C.VR:K,#)
ME#,>::(;[84:MFXI-JU5T25;()*));:2<-P`-HD&;M0XMNA'4M$`"*`]FBD#
M038Y&)HATTT==!2.@[.6&B0_5LGJRSEIC7#?.4\A_.PD7</M!X8ZC]FD,ZWD
M-LRKVH=A\Z\\1OARL^?X_(+)K^/OK`(2`V?1J&*-T2\+3&T:(;OHPF8:,I*7
M=SB/GMF+Z5N'\AD3B447^(]82VC^9N7>>;,JD!V5KSC%W?8/2/L3,+\\U9S#
M-H9&XW'K)?R>+&Q49-WS<1R6J%7\9KNLFW[8]^J&&'CA^-R=&B;@KJ,QQ\;&
M25Z!#.Y$$;O&@8\Y%L%S0EJ1T_3(-QA95ON0'H/D_P#EO$6;E%)UI_P+Z*:Y
MSCR,WJ;TJ>LKM.]->D.F.7(_9UOJ!@X`E)GDTLX`WD`R.L<C0"<C`1.:@@!Q
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MI:RK8;**DK21CJ;D`B65&/.06,%&-7R>/BW@0#(:]9/1BS6&F0@=^\&"24>1
M'NAK!RLU9JHI;YU\"NE4'.GOOZ-U?]\#.]8[QI,+X<)2")>NJTJ29W/2=6TV
MT'*M:L!RTZK)E3D8M,^)5:RVR",2`##>I@O^WG_T7@K^EPN>04P_$R1'1LQE
M5/>HRVDAV%4'1B.6ETA71&1ZX>)X1>I-24??CPR^S+"F%F^6JJ'ZNV%M-<92
MU:K6",8QC[8_\_\`W.?\Y_G.?'@1C\AH>V:768I/>X"'&M0U.QCYH<#H#F]C
M8MG3(X>(;"=A<FG5VS]R!'"$@&J)9)",0R(NT2N7B#D@;3U1U:IO)./'@,XQ
MG[9Q\X_UGSC&NNOVUQC&/]8QC'_UYSX\!X\>/`>/'CP'CQX\!YI_WUUE#^'>
M.^A.I)F4"#FU15C*))'69UXW:-I//]1;EM7<+:X7<M=G9*8358(`8,6ROU3I
M5[G1#7.V,YUW`\PU?_/5*]3U1*:.Z$K>,6Q4\TT&ZR6$2YFH\#D]@Y5F;$N-
MOIUVKQJ\&%Q[(B/?L';1ZS=MDUF[A/;&?D(F?PZ%(':@]5-#RR9D7!6QNHR<
MXZ_L4@Y:.F2CN1]`'U),-WW2>J*.=UDX8VBJ;ESOG71VZPNZ1QLBLGOM.7YU
M8,('C083'8\+8!`($8/"A`PIHBP&"1`IHBP&C!S%MHFW9L&#)N@T9M4$]$6[
M=%-%+35/377':>`\>/'@/'CQX#QX\>`\>/'@/'CQX#QX\>`\>/'@/'CQX'__
!V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>exhibit991image111613.gif
<TEXT>
begin 644 exhibit991image111613.gif
M1TE&.#EAE@`X`/8``````/WW^OF_X?O7[(H?`Y<;%>P`C,@,6>`Y/N=D:.AK
M;NAH;.125N$_1.Z0D_"<G_2[O/?-S_G:V_____[Y^?&HJNM]@>9>8OSL[?OF
MY_*NL.-,4.EQ=/7!POC4U?.TMNR$A_;'R>IW>_K@X>587/"BI/WS\^^6F>)%
M2NV*C>AI;>R#A?&CIO?+S/2UM_">H/OGZ/2YN_G8V?C0T??*R_&BI?C.S_.R
MM.R'B?*LKO?'R?2ZO.V,D.Z/DNZ1E.Z1D^M_@9,<$-0(:K@01```````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````````````````````"'Y!`$``$0`
M+`````"6`#@```C_`(D('$BPH,&#"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQ
MH\>/"2<(&"E@`,B3&`FH7,FRI<N7,&/*+&"@IH$#*Q'HW,FSI\^?0(,*'4KT
M)Q&92),JC4G3)DZ51:-*G4I5Z-&E6+,RM7DS9]6O8,/ZO*JU;-FF-9\2$,NV
M[52R9N,J1=L5JMN[>,?*W9N4KMJ\@//"Y4N8I5^O@1.+'5RX\&&[BB-79=R8
M[^.UDC-+I5Q9[F7-H(ER[FSV<^C31DDW-BTY@>O7L%\SR#Q:=5;6;1LD.'$"
M@@T)$X(+#PY\^'`;-BJ<P#'[;FW;2W%_W6T#0W`,R7F_'HK"M0C>R(5+_X!@
MH3G8Y]#[<OU;M8$(&]<AG$BP<P-/',HA0*B!8J>(&B=4<(%/*'P'07`9Y&#>
M6^GM)1U1#%1@704B-(```_8AD,`$$/`$GW$ZG6#<"3I-D,%."5B8``[`V2`"
M5>@UN)53B$%XH`0X6*C3AC7LR*&'$UB0P`7PZ03?:\"5.,&+"&"``0+N75C!
M!!B0&%6,,K[T(%`BVL!``R?8`,&7&UJYX0U`-G?#!#I9MU.1"`1709L27!C<
M#?3A@($$"P:%998M;=D3"C90D..4PLW)HX\=OCE!A@?.YJ:1;,8Y09U-/MD`
M!-9=6N&!5EH%Z%GKU0@4!398^&$%+"HZ@94*3/^`YDXM3-#<E+,E2:F2CR(@
MP9,['1C<BV4.]>>H*@FZDX@ZPF?A!C\NJJ&L/-4:[`3T38J`M99.@$.F/'4I
M7X@3].<GLK>5"ME/#7CKZ&P,3&"#G;#^2&NE"*R9+;[<"M?AK^%.H.A.XXF*
M;G3J8@84!)CJ5"N\$[1@9X_3SGGOM?1QNVVE5`;79,,(B#@KBK:>>_!<"0?5
M+I,.EQROQ/'6VVC+.TV9,;\<2U!K`DX&'.J;%J=VLGHTKMM3O/3="S',$U!\
M9K7X'OBBQOUBP(/``.]4PZL^W3"S7D,CI6R[WRIM)],R0[V3OAM?'"<&\6:P
M9\`4\R3!SST=BZRR(<__:_;+$_L8],:O,3P;U3DW&;'$RW)]7Z]`Z3TJWPU@
M$/3#9].K4ZQ?USI<HXB7^"2BP)+[<[L\&!SVC&F9ZI,([F[\(N`Q^SCRQ@`N
MYW;;<9X(NXD\;5VV3IP:N_I,*0^U<[[75=!"A]`Z;2_-/H4>)Z8(!CR\S<8?
M#U,0R0\E8@4-,+!F<"36CD"L@VNL-O54MGSBLAC01P(&+62HNO>!AC\4`[_*
M40-P4+9V66XY$F@?OM['N_@A``<.U`F9.*6`*_'O)>`KFL**PB(.L0P!(NC4
ML!@(-=XXKU&7DF`&9C9`X`Q.-!=T"=^`(H):68XY$N3-!WG7$Q(,IW[$P]MN
MYFQ(/IV(``<\P!O88KB2#+;.:%,1@;`BQJJD\60#5O3)=GJR&X9=YP3ZVY$%
MYM,])B;+?V#9@`6<)QS\M8`W-<!!;!*@@#HJX`0`<EYQJ/3&+/9$!+O9X1+-
MZ,2Z;-`MNOG."3S0@D:*<(\18^3S3L`#UT0E`8`49-[,N)(9HD8RD@-4(=GS
MR5*&,DN>+&5B3BFC4;I.E9IA98-2"4O!<%(EKH1B+4%Y2P+0<I=ND65Z<GE(
M8$9&F-#YI3$7TTMB+C.6O53F,[^"3.@(X9I"&,(KIXD7E'CSF^`,ISC'2<YR
(FO.<%@D(`#L_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
